Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study investigates the effects of dry needling on spasticity and its impact on functional ability in individuals with neuromuscular disorders. Using the Modified Ashworth Scale (MAS), Timed Up and Go (TUG) test, and Gross Motor Function Measure (GMFM), the research evaluates changes in muscle tone, mobility, and overall motor performance following dry needling intervention. The findings aim to provide evidence on the clinical benefits of dry needling as a therapeutic approach for improving movement efficiency and functional outcomes in patients with spasticity.
Spasticity is a common impairment in individuals with neuromuscular disorders, often leading to limitations in movement, balance, and overall functional performance. Dry needling has emerged as a promising intervention for managing spasticity by targeting hyperactive muscle fibers and reducing abnormal muscle tone. This study aims to explore the therapeutic effects of dry needling on muscle spasticity and functional ability using standardized clinical measures.
Participants will undergo pre- and post-intervention assessments using the Modified Ashworth Scale (MAS) to quantify changes in muscle tone, the Timed Up and Go (TUG) test to evaluate mobility and balance, and the Gross Motor Function Measure (GMFM) to assess functional motor skills. The intervention will focus on specific muscle groups affected by spasticity.
By analyzing the relationship between changes in spasticity and functional mobility, this study seeks to determine whether dry needling contributes to measurable improvements in movement efficiency, postural control, and daily functional activities. The findings will provide valuable insights into the role of dry needling as an adjunct therapy in rehabilitation programs, supporting its integration into clinical practice for individuals with neuromuscular disorders.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Traditional physical therapy Group | Active Comparator | Traditional physical therapy program based on neurodevelopmental treatment (NDT) (3 sessions per week, each lasting 1 hour). |
|
| Dry needling Group | Experimental | traditional physical therapy program based on neurodevelopmental Treatment (NDT) (3 sessions per week, each lasting 1 hour), in addition to dry needling for the spastic calf and adductor muscles. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Traditional Physical Therapy | Other | Traditional Physical Therapy based on neurodevelopmental technique |
|
| Measure | Description | Time Frame |
|---|---|---|
| Modified Ashwarth Scale (MAS) | The MAS measures spasticity on a 6-point ordinal scale from 0 to 4, with an additional 1+ category. Minimum Value (0): No increase in muscle tone (better outcome). Maximum Value (4): Affected part(s) rigid in flexion or extension (worse outcome). Higher scores indicate greater spasticity, representing a worse outcome. | Week 12 after intervention completion |
| Measure | Description | Time Frame |
|---|---|---|
| Gross Motor Function Measure (GMFM) | The GMFM is scored on a 0 to 100% scale, reflecting the percentage of motor tasks successfully performed. Minimum Value (0%): No motor function achieved (worse outcome). Maximum Value (100%): Full achievement of all motor tasks (better outcome). Higher scores indicate better gross motor function and improved mobility. | Week 12 after intervention completion. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| BMC | Jeddah | Saudi Arabia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002547 | Cerebral Palsy |
| D009128 | Muscle Spasticity |
| ID | Term |
|---|---|
| D001925 | Brain Damage, Chronic |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000079245 | Dry Needling |
| ID | Term |
|---|---|
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
Not provided
Not provided
The study follows a randomized controlled trial (RCT) design with a parallel-group interventional model to evaluate the effects of dry needling on spasticity and functional outcomes. Participants are randomly assigned to one of two groups:
Study Group (Intervention Group): Receives dry needling for the spastic calf and adductor muscles in addition to a traditional physical therapy program based on Neurodevelopmental Treatment (NDT) (3 sessions per week, each lasting 1 hour).
Control Group: Receives only the traditional physical therapy program (NDT) without dry needling, following the same frequency and duration.
Not provided
Not provided
Not provided
|
| Dry Needling | Other | Dry Needling in addition to the same traditional physical therapy program |
|
|
| Time up and go test (TUG) | The TUG test measures the time (in seconds) taken to stand up from a chair, walk 3 meters, turn around, walk back, and sit down. Minimum Value (lower time in seconds): Faster completion time indicates better mobility and functional performance. Maximum Value (higher time in seconds): Slower completion time indicates impaired mobility and a higher risk of falls (worse outcome). | Week 12 after intervention completion |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D009122 | Muscle Hypertonia |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |